Pimasertib (Compound)

Synonyms:Pimasertib, 1236699-92-5, AS703026, AS-703026, Pimasertib (AS-703026), AS 703026, MSC1936369B, (S)-N-(2,3-dihydroxypropyl)-3-(2-fluoro-4-iodophenylamino)isonicotinamide, 1204531-26-9, MSC-1936369, 6ON9RK82AL, MSC1936369A, MSC-1936369A, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]pyridine-4-carboxamide, SAR 245509, EMD 1036239, EMD-1036239, (S)-N-(2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide, 4-Pyridinecarboxamide, N-((2S)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)-, N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodo-anilino)pyridine-4-carboxamide, G-02443714, AS7030261236699-92-5, (S)-N-(2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide., 4-Pyridinecarboxamide, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-, N-((2S)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)pyridine-4-carboxamide, Pimasertib [INN], Pimasertib [USAN:INN], UNII-6ON9RK82AL, Pimasertib (USAN/INN), PIMASERTIB [USAN], Pimasertib; AS703026, N-[(2S)-2,3-Dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-4-pyridinecarboxamide, PIMASERTIB [WHO-DD], MLS006010177, GTPL7872, SCHEMBL2720659, CHEMBL2107832, CHEBI:94793, DTXSID40152870, EX-A403, BCPP000386, BCP02094, BDBM50014412, NSC755763, NSC800854, AKOS022186348, BCP9000325, CCG-269018, CS-0198, DB14904, NSC-755763, NSC-800854, NCGC00346530-01, AC-32862, AS-16324, HY-12042, SMR004701285, AS703026,MSC1936369B, SW219691-1, C71933, D10426, A857420, J-523298, BRD-K89014967-001-01-9, Q27088393, AS-703026;N-[(2S)-2,3-Dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-4-pyridinecarboxamide;AS-703026

Pubchem:PUBCHEM:44187362

Id:ba3dff7d-9795-5c39-a6b4-7fd89ca7a11b

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Pimasertib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Pimasertib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Pimasertib.

Results found

Linked to

	Label	Description
	BRD-K89014967-001-04-3 Substance (Entity type)	A Substance
	pimasertib (2d9947d2-2756-4333-b711-902b84b5e1a7) Collection (Entity type)	Metadatata for pimasertib
	Pimasertib positively regulates HSPB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib positively regulates MATN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib negatively regulates HMGA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib positively regulates GSTA4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib negatively regulates DUSP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib negatively regulates ODC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib positively regulates WFDC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pimasertib in similarity relationship with cobimetinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS